Skip to main content

Silexion Therapeutics Corp 8-K, filed Sep 25, 2026

Silexion Therapeutics Corp (SLXN)

8-K 2026-09-25 For: 2026-09-25
View Original
Added on September 26, 2026

About this 8-K

Silexion Therapeutics Corp filed this 8-K on September 25, 2026.

On September 25, 2026, Nasdaq notified Silexion Therapeutics Corp of a bid-price deficiency after 30 consecutive business days below $1.00 per share under Listing Rule 5550(a)(2). The hearings panel will consider Nasdaq Capital Market listing; shares and warrants continue trading. AI summary

Items reported

  • Item 3.01: Delisting notice or listing transfer